Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
After finishing at $16.51 in the prior trading day, Denali Therapeutics Inc (NASDAQ: DNLI) closed at $16.27, down -1.45%. In other words, the price has decreased by -$1.45 from its previous closing price. On the day, 1.18 million shares were traded. DNLI stock price reached its highest trading level at $16.685 during the session, while it also had its lowest trading level at $15.69.
Ratios:
Our goal is to gain a better understanding of DNLI by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.79 and its Current Ratio is at 9.79. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
On February 11, 2025, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $31.Deutsche Bank initiated its Buy rating on February 11, 2025, with a $31 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 04 ’25 when CAROLE HO bought 1,882 shares for $19.00 per share.
Schuth Alexander O. sold 2,937 shares of DNLI for $39,884 on Aug 12 ’25. The COFO and Secretary now owns 242,346 shares after completing the transaction at $13.58 per share. On Aug 12 ’25, another insider, Ho Carole, who serves as the Chief Medical Officer of the company, sold 2,937 shares for $13.58 each. As a result, the insider received 39,884 and left with 217,391 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DNLI now has a Market Capitalization of 2540696832.
Stock Price History:
The Beta on a monthly basis for DNLI is 1.05, which has changed by -0.17911202 over the last 52 weeks, in comparison to a change of 0.14778805 over the same period for the S&P500. Over the past 52 weeks, DNLI has reached a high of $24.34, while it has fallen to a 52-week low of $10.57. The 50-Day Moving Average of the stock is -5.37%, while the 200-Day Moving Average is calculated to be 7.82%.
Shares Statistics:
The stock has traded on average 1.58M shares per day over the past 3-months and 1121040 shares per day over the last 10 days, according to various share statistics. A total of 146.63M shares are outstanding, with a floating share count of 138.96M. Insiders hold about 11.01% of the company’s shares, while institutions hold 89.38% stake in the company. Shares short for DNLI as of 1765756800 were 13092563 with a Short Ratio of 8.29, compared to 1763078400 on 14017386. Therefore, it implies a Short% of Shares Outstanding of 13092563 and a Short% of Float of 9.3100004.
